GlassScriptPhysician profile
Chris B Sandberg
NPI 1639147408
$2,537.34
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $776 · 2021: $1,025 · 2022: $160.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $287.50 | 2019-2022 | |
| Lilly USA, LLC | $212.15 | 2020-2022 | |
| Astellas Pharma US INC | $199.07 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $195.98 | 2019-2022 | |
| Glaxosmithkline, LLC. | $161.50 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $110.88 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $102.45 | 2020-2021 | |
| Currax Pharmaceuticals LLC | $94.08 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $91.27 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $90.72 | 2019-2021 | |
| Abbvie INC. | $89.32 | 2021 | |
| Merck Sharp & Dohme LLC | $85.62 | 2019-2021 | |
| Pfizer INC. | $84.77 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $79.01 | 2019-2022 | |
| Boston Scientific Corporation | $78.00 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $70.47 | 2020-2021 | |
| Amarin Pharma, INC. | $67.20 | 2019-2020 | |
| Mylan Specialty L.P. | $50.06 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $45.44 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $45.27 | 2020 | |
| Novo Nordisk INC | $43.78 | 2020-2021 | |
| Eisai INC. | $39.96 | 2020-2021 | |
| Allergan, INC. | $34.63 | 2020-2021 | |
| Abbott Laboratories | $28.52 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.92 | 2019 | |
| Genentech USA, INC. | $25.07 | 2021 | |
| Bausch Health US, LLC | $19.86 | 2021 | |
| Amgen INC. | $18.91 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.45 | 2022 | |
| Phadia US INC. | $14.51 | 2021 | |
| Circassia INC. | $13.50 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.47 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Sandberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.